Opioid Induced Constipation Drugs Market - Industry Trends and Forecast

The global opioid-induced constipation drugs market is estimated to witness significant growth during the forecast period. The prolonged use of opioids can harm the sensory system which causes body cells to quit creating endogenous opioids, such as endorphins. Adults have a huge risk of constipation as they tend to have a poor diet, poor fluid intake, and immobility. Generally, the patients opt for over-the-counter osmotic laxatives and stimulant cathartics, which have been beneficial in relieving constipation in patients taking opioid analgesics for 3-4 weeks.

Data Bridge Market Research analyses a growth rate in the opioid induced constipation drugs market in the forecast period 2023-2030. The expected CAGR of opioid induced constipation drugs market tends to be around 6.7% in the mentioned forecast period. The market was valued at USD 2.52 million in 2022, and it would grow up to USD 4.23 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Access Full Report:
https://www.databridgemarketresearch.com/reports/global-opioid-induced-constipation-drugs-market

Drivers

Rising Incidence of Kidney Diseases
The rise in kidney disorders can be attributed to lifestyle changes such as consuming unhealthy food high in calcium and other minerals. For instance, per the records of the global burden disease 2015 study, around 1.2 million people in the world died due to kidney failure in 2015, a 32% rise since 2005. Thus, this boosts market growth.

Increasing Diversified Treatments
Several diversified treatments are available for the diseased condition and thus are contributing to boosting the market growth. Lubiprostone is indicated for treating opioid-induced constipation drugs, with its major indication for chronic idiopathic constipation (CIC). Lubiprostone is anticipated to take over the market share of methylnaltrexone bromide. Furthermore, naloxegol is projected to grow at the highest CAGR during the forecast period. The drug is under testing for many patient types, such as pregnant women and patients less than 17 years of age. So, future approvals are estimated to dominate the market.

Opportunities

Increasing Demand for Retail Pharmacies
The increase in opioid-induced constipation drugs delivered through retail pharmacies and the increase in the number of pharmacies in highly developed countries create opportunities for market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily available.

Increasing Use of Opioids
In 2014, it was reported that more than six out of 10 deaths were due to opioid overdose, which included and opioid pain relievers. The maximum number of deaths witnessed because of synthetic variants, that included 5,500 deaths in 2014. Considering the increased death rate related to opioid dependency and abuse, governments in the US and other countries advocate against using these substances. Thus, it creates an opportunity for market growth.

Restraints/Challenges

Patent Expiration Encourages New Launches
The patent expiration of old companies can create better opportunities for new market players. Adopting combination therapies is a significant factor contributing to the growth of the opioid-induced constipation drugs market. Further, R&D fundings are an add-on to the market

Opioid Tolerance And Addiction
The patient may become tolerant and need more and more drugs to achieve the effect in smoothing the pain. Additionally, using opioids for a prolonged period of time can develop dependency. After withdrawing the drug, the patient may suffer from withdrawal symptoms such as anxiety, drug cravings, irritability, tremors (shaking), and others.

This global opioid induced constipation drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global diuretic drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Key players operating in the global opioid induced constipation drugs market include:

Pfizer Inc (US.)
F. Hoffmann-La Roche Ltd (Switzerland)
Mylan N.V. (U.S.)
Fresenius Kabi AG (Germany)
Hikma Pharmaceuticals PLC (UK.)
Novartis AG (Switzerland)
Teva Pharmaceutical Industries Ltd. (Israel)
Bristol Myers Squibb Company (US.)
GSK Plc. (UK.)
Bayer AG (Germany)
Aurobindo Pharma (India)
S.L.A. Pharma AG (U.K)
Salix Pharmaceuticals (US.)
Takeda Pharmaceutical Company Limited (Japan)
Abbott(US.)
Boehringer Ingelheim International GmbH. (Germany)
Merck & Co Inc. (US.)
Daewoong Pharmaceutical Company (South Korea)
Cosmo Pharmaceuticals (Ireland)

Browse More Links:

https://healthcarestrends24.blogspot.com/2024/03/feminine-hygiene-products-market.html

https://healthcarestrends24.blogspot.com/2024/03/bionic-eye-market-industry-trends-and.html

https://healthcarestrends24.blogspot.com/2024/03/bone-growth-stimulation-devices-market_14.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.